Improving T cell therapy: in vivo CRISPR-Cas9 screens tell us how to do

Precis Clin Med. 2021 Jul 22;4(3):176-178. doi: 10.1093/pcmedi/pbab015. eCollection 2021 Sep.

Author

Tao Yin¹

Affiliation

¹ Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27708, USA.

Abstract

A commentary on "In vivo CD8⁺ T cell CRISPR screening reveals control by Fli1 in infection and cancer".

© The Author(s) 2021. Published by Oxford University Press on behalf of the West China School of Medicine & West China Hospital of Sichuan University.